IntelGenx Technologies Corp. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-10-07: Form 8-K; Period of report 2024-10-02; Description 2.01 Completion of Acquisition or Disposition of Assets; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 2.01.
- 2024-07-23: Form 8-K; Period of report 2024-07-19; Description 8.01 Other Events; Details 8.01.
- 2024-06-07: Form 8-K; Period of report 2024-05-27; Description 8.01 Other Events; Details 8.01.
- 2024-05-21: Form 8-K; Period of report 2024-05-17; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2024-10-07 | 8-K | 2024-10-02 | 2.01 Completion of Acquisition or Disposition of Assets; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 2.01 On September 30, 2024, IntelGenx Technologies Corp. (the "Company") and its subsidiary IntelGenx Corp. ("IGX" and, together with the Company, the "IGX Entities") obtained an approval and vesting order (the "Approval and Vesting Order") from the Superior Court of Québec (Commercial Division) (the "Court") issued in connection with the previously announced proceedings instituted pursuant to the Companies' Creditors Arrangement Act (the "CCAA"). 5.02 On October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions. | form8k.htm |
| 2024-07-23 | 8-K | 2024-07-19 | 8.01 Other Events | 8.01 On July 19, 2024, IntelGenx Technologies Corp. (the "IntelGenx") announced that the Phase 1 Non-Binding LOI Submission Deadline set for 5:00 p.m. | form8k.htm |
| 2024-06-07 | 8-K | 2024-05-27 | 8.01 Other Events | 8.01 On May 27, 2024, IntelGenx Technologies Corp. ("IntelGenx") obtained an order from the Québec Superior Court (Commercial Division) (the "Court") approving the implementation of a sale and investment solicitation process (the "SISP Approval Order") intended to generate interest in either the business or the assets of IntelGenx, or in a recapitalization of IntelGenx, with the goal of implementing one or more transaction(s) (the "SISP"). | form8k.htm |
| 2024-05-21 | 8-K | 2024-05-17 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 5.02 On May 17, 2024, the Board of Directors ("Board") of IntelGenx Technologies Corp. (the "Company") received the resignations of Clemens Mayr, Sahil Kirpekar and Ryan Barrett, effectively immediately (the "Resignations"). 7.01 On May 17, 2024, the Company issued a press release announcing that the Board has authorized the Company and its subsidiary, IntelGenx Corp., to implement a restructuring plan under the Companies' Creditors Arrangement Act (Canada) (the "CCAA"). | form8k.htm |
| 2024-05-08 | 8-K | 2024-05-07 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 IntelGenx Technologies Corp. (the "Company" or "IntelGenx") held its Annual Meeting of Shareholders on May 7, 2024 (the "Annual Meeting"), in a virtual-only format, for those who were shareholders of the Company at the close of business on March 11, 2024 (the "Record Date"), pursuant to notice and proxy materials duly communicated to them. | form8k.htm |
| 2024-03-25 | 8-K | 2024-03-11 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Pursuant to the Loan Agreement, amongst other things, atai has agreed to make (i) one (1) additional term loan in the amount of US$1,000,000 to IntelGenx Corp., which loan is to be disbursed within three (3) business days of the execution of the Loan Agreement (the "First Tranche Loan"), and (ii) one (1) additional term loan in the amount of US$1,000,000 to IntelGenx Corp., which loan is to be disbursed upon the achievement of a pre-defined milestone (the "Second Tranche Loan" and collectively with the Second Tranche Loan, the "Additional Term Loans"). 3.02 The information set forth under Item 1.01 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 3.02 in its entirety. | form8k.htm |
| 2024-02-20 | 8-K | 2024-02-14 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | form8k.htm |
| 2024-02-14 | 8-K | 2024-02-08 | 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 3.03 To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference. 5.03 On February 8, 2024, IntelGenx Technologies Corp. (the "Company") filed the Certificate of Designations of Preferences, Rights and Limitations of Series A Convertible Cumulative Preferred Stock (the "Certificate of Designation") designating 2,090,000 shares of Series A Preferred Stock of the Company. | form8k.htm |